Results 71 to 80 of about 10,516 (266)

Prolactinomas [PDF]

BMJ, 1985
Grossman, A, Besser, G
openaire   +6 more sources

FRI300 Prolactinoma And Pregnancy: A Systematic Review And Meta-analysis [PDF]

, 2023
Diego Barata Bandeira, Letícia Santana Alves, Andréa Glezer, César Luiz Boguszewski, Vania Santos Nunes-Nogueira   +4 more
openalex   +1 more source

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

Equine Veterinary Education, Volume 38, Issue 3, Page e170-e179, March 2026.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess, A. Bracken, S. Rao, Y. Nout‐Lomas, D. Gustafson, L. Bass   +5 more
wiley   +1 more source

Additional file 3 of The SF3B1R625H mutation promotes prolactinoma tumor progression through aberrant splicing of DLG1

, 2022
Additional file 3: Figure S2.SF3B1-R625H alters the transcriptome in GH3 cells and human prolactinoma. (A) Volcano plot comparing mRNA expression between Sf3b1 mutant vs. wild-type GH3 cells.
Jing Guo (102972), Yulou Liu (10705962), Qiuyue Fang (9913857), Yazhuo Zhang (3703210), Dawei Wang (471687), Chuzhong Li (3703216), Yiyuan Chen (2715826), Weiyan Xie (7587713)   +7 more
core   +1 more source

Proteomic insights into the invasiveness and tumor progression of non‐functioning pituitary adenomas: A scoping review

Journal of Neuroendocrinology, Volume 38, Issue 3, March 2026.
Abstract Nonfunctioning pituitary adenomas (NFPAs) are common intracranial tumors that, despite being histologically benign, can exhibit invasive growth, as well as postoperative tumor progression. Surgical resection is the primary treatment of choice; however, residual tumor tissue is frequently observed, with between 30% and 50% of these cases ...
Thomas Skoglund, Linus Köster, Annika Thorsell, Oskar Ragnarsson, Gudmundur Johannsson, Tobias Hallén   +5 more
wiley   +1 more source

Premature pubarche as a first presentation of pituitary macroprolactinoma

Journal of Research in Medical Sciences, 2020
Prolactinoma is a rare tumor of childhood. Clinical presentations of prolactinoma include amenorrhea, delayed puberty, and galactorrhea. For the first time, in this case, elevated prolactin levels were associated with unexpected premature pubarche.
Fatemeh Tabatabaei, Mohammad Reza Sharif, Hossein Nasr Esfahani, Razieh Yazdi Zahrani, Abolfazl Taheri, Rokhsareh Meamar   +5 more
doaj   +1 more source

FRI322 Lack Of Tumor Size Change With Long-term Cabergoline For Prolactinoma [PDF]

, 2023
Snigdha Reddy Bendaram, Vitaly Kantorovich   +1 more
openalex   +1 more source

Serum vaspin and adiponectin levels in patients with prolactinoma

, 2016
Background: Studies investigating serum vaspin and adiponectin levels in patients with prolactinoma are inconclusive. The aim of this study was to evaluate serum vaspin and adiponectin levels in patients with prolactinoma and healthy controls. Methods: A
Ozturk, Gulfer, Arslan, Muyesser Sayki, Ucar, Fatma, Delibasi, Tuncay, Ginis, Zeynep, Erden, Gonul, Erdogan, Serpil, Akyol, Sumeyye   +7 more
core   +1 more source

MicroRNA networks in prolactinoma tumorigenesis: a scoping review

Cancer Cell International
Background Prolactinoma is the leading type of pituitary adenoma. Aside from the mass-like effect of prolactinoma, its hormonal effect is the main pathological cause of endocrine dysregulation and infertility.
Sevil Ghaffarzadeh Rad, Fatemeh Nejadi Orang, Mahdi Abdoli Shadbad   +2 more
doaj   +1 more source

A Retrospective Study on the Impact of Primary Aldosteronism in Pregnancy (H.A.P.P.I. Study Group)

Clinical Endocrinology, Volume 104, Issue 2, Page 113-122, February 2026.
ABSTRACT Objective Primary aldosteronism (PA) is a common cause of hypertension in young women. However, there is a paucity of data regarding its impact during pregnancy. The primary objective of this study was to describe the occurrence of hypertensive disorders of pregnancy (HDP) in PA.
Diana Oprea, Frédérique Lefrançois, Matthieu St‐Jean, Anne‐Marie Côté, Marie‐Ève Roy‐Lacroix, Mandy Malick, Pierre‐Luc Mallet, Nadine Sauvé   +7 more
wiley   +1 more source